| Filed On | Filing |
|---|---|
| 21 May 2020 | 15-12B |
| 18 May 2020 | EFFECT |
| 18 May 2020 | EFFECT |
| 18 May 2020 | EFFECT |
| 18 May 2020 | EFFECT |
| 14 May 2020 | POS AM |
| 14 May 2020 | POS AM |
| 14 May 2020 | POS AM |
| 14 May 2020 | POSASR |
| 14 May 2020 | POS AM |
| 14 May 2020 | S-8 POS |
| 14 May 2020 | S-8 POS |
| 14 May 2020 | S-8 POS |
| 14 May 2020 | S-8 POS |
| 14 May 2020 | S-8 POS |
| 14 May 2020 | S-8 POS |
| 14 May 2020 | S-8 POS |
| 14 May 2020 |
8-K: Material Modification to Rights of Security Holders
On May 14, 2020 (the “Settlement Date”), AbbVie Inc. (“AbbVie”) completed its previously announced (i) offers to exchange (each, an “Exchange Offer” and, collectively, the “Exchange Offers”) any and all outstanding notes of certain serie... |
| 12 May 2020 |
Form 4: Basgoz Nesli, Director
Returned 6,888.913 shares to the issuer · Disposed of 9,100 Stock Options (Disposition to Issuer) |
| 12 May 2020 |
Form 4: Boccuzi Joseph H, Director
Returned 3,605 shares to the issuer |
Loading...